Form 4: CalciMedica Director Fred A. Middleton Reports Stock Purchases

Director Fred A. Middleton reports purchasing shares of CalciMedica, Inc. both directly and indirectly through associated investment funds.

Summary

• On November 1, 2024, Fred A. Middleton, a director of CalciMedica, Inc., reported the purchase of CalciMedica common stock.
• Mr. Middleton directly acquired 20,000 shares at a price of $3.75 per share.
• He also indirectly acquired 86,867 shares through Sanderling Venture Partners VI Co-Investment Fund, L.P. at $3.75 per share.
• Additional indirect holdings are attributed to various Sanderling Ventures entities, Golden Triangle Ventures, LLC, and other related funds, with Mr. Middleton disclaiming beneficial ownership except to the extent of his pecuniary interest.
• Following these transactions, Mr. Middleton directly owns 31,714 shares and indirectly owns a total of 1,668,383 shares through various entities.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying is generally viewed favorably, but the filing primarily reflects transactions and disclaimers of beneficial ownership.

Positives

• The director's purchase of shares may signal confidence in the company's future prospects.
• Increased insider ownership can align management's interests with those of shareholders.

Industry Context

Insider trading activity is closely monitored as it can provide insights into a company's performance and future prospects. Purchases by insiders are often seen as a positive sign.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive signal.
• The increased insider ownership could potentially align management's interests more closely with those of shareholders.

Key Dates